Physician profile
Joseph Guarnieri
NPI 1033165451
$2,519.11
in general payments reported to CMS, 2019-2025
19 companies · $54.70 in 2025
The $54.70 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $401 · 2021: $450 · 2022: $490 · 2023: $258 · 2024: $274 · 2025: $54.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $787.89 | 2019-2022 | |
| Alcon Vision LLC | $414.35 | 2019-2025 | Rocklatan, Hydrus Microstent |
| Aerie Pharmaceuticals, INC. | $275.44 | 2019-2021 | |
| Abbvie INC. | $207.19 | 2022-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $181.72 | 2019-2021 | |
| Oyster Point Pharma, INC. | $122.16 | 2022-2023 | Tyrvaya |
| Omeros Corporation | $97.99 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $95.33 | 2019-2022 | |
| Harrow Eye, LLC | $50.12 | 2024 | Vevye |
| Rayner Intraocular Lenses Limited | $49.72 | 2023 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Apellis Pharmaceuticals, INC. | $48.07 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $36.30 | 2024 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $32.57 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $24.82 | 2021 | |
| Shire North American Group INC | $24.47 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $23.02 | 2022 | |
| Horizon Therapeutics Plc | $17.37 | 2022 | |
| Vyera Pharmaceuticals, LLC | $16.27 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $14.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Guarnieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.